• br compared with the control Fig C

  2022-05-19

  

   compared with the control (Fig. 4C). Furthermore, DNA damage was assessed in Mar-C treated A549 Tacrolimus with neutral comet assays. Results in Fig. 4D demonstrated a time-dependent increase of DNA breaks upon Mar-C treatment, as reflected by tail moment. Considering DNA damage occurred at an

• br Corresponding author Department of Surgery V astmanland s

  2022-05-18

  

  * Corresponding author. Department of Surgery, V€astmanland's Hospital V€asterås, SE-72189, V€asterås, Sweden. E-mail address: [email protected] (I. Sverrisson).  anastomotic leakage (AL), pelvic abscesses and deep perineal wound infections [14e16]. Increased surgical

• br www molecularmetabolism com br Figure Fluvastatin can be

  2022-05-13

  

  www.molecularmetabolism.com Figure 2: Fluvastatin can be measured in the mouse prostate. Male NOD/SCID mice were treated with PBS or 50 mg/kg/day fluvastatin by oral gavage for 4 consecutive days. 2 h after the last treatment, serum samples were collected, the mice were euthanized and prostate

• b iframe width height src https

  2022-05-13

  

  r> that occur in stomach microhabitats during GC development. Previous studies on colorectal cancer have suggested that different bacterial spe-cies preferentially inhabit the tumor sites but not tumor-free sites [41,42]. The altered gastric microbiota influences inflammation and im-munity both loc

• br distinguishing the extent of invasive tumour from DCIS compo

  2022-05-10

  

   distinguishing the extent of invasive tumour from DCIS compo-nents using mammography and also using tomosynthesis. Variability in measurement was comparable for both tomo-synthesis and mammography, but was greater in dense breasts for both tests. For women with high breast density, 95% LOA i

• br d Department of Gynecological Oncology

  2022-05-10

  

  d Department of Gynecological Oncology, McGill University Health Centre, Cedars Cancer Centre, Canada • Adding chemotherapy didn't improve the survival compared to radiation therapy alone. • Grade 3 disease was an independent predictor for worse outcomes. • Patients with grade 3 disease a

• b iframe width height src https

  2022-05-09

  

  r> ∗ Corresponding author. Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou, 510632, China. ∗∗ Corresponding author. Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou, 510632, Ch

• br Introduction br Breast cancer patients commonly undergo computed tomography

  2022-05-06

  

  1. Introduction Breast cancer patients commonly undergo computed tomography (CT) chest imaging [1]. At CT chest coincidental coronary artery calcifi-cation (CAC) may be detected [2]. CAC denotes calcified coronary atherosclerosis and predicts cardiovascular mortality [3]. Cardiovascular disease

• br d Engineered MSC did

  2022-05-06

  

  (d) Engineered MSC did not induce significant tissue damage. Quantifications were done on the H&E staining: percentage of connective tissue to assess spleen fibrosis, number of goblet MK-571 per villus to evaluate intestine damage, and number of leukocytes per bone marrow area to measure toxicity

• br Inhibition of endometrial cancer cell

  2022-05-04

  

  3.6. Inhibition of endometrial cancer cell growth following MET+SIM treat-ment is partially mediated by AMPK activation and mTOR pathway effects The mTOR pathway has been a proposed key target in MET- and SIM-associated inhibition of endometrial cancer cells as well as in other cell types inclu

• br For both groups the breast cancer screen eligible population

  2022-05-04

  

  For both groups, the breast cancer screen−eligible JNJ-42153605 included women who were aged 50 to 69 for the 3 years before and 3 years after the index date, which was the date of the admis-sion leading to the initial release for the corrections group and July 1, 2010 for the general population.

• br The Gynecologic Oncology Group GOG has

  2022-04-29

  

  The Gynecologic Oncology Group (GOG) has conducted multiple clinical trials investigating optimal chemotherapy regimens in the treat-ment of advanced, recurrent, and metastatic cervical cancer. GOG 179 was the first such trial to demonstrate a significant survival advantage in patients treated wit

• br G PDH was used

  2022-04-29

  

  G PDH was used as an internal control to calculate the relative expression levels of the target genes (Li et al., 2016). 2.5 Western blotting analysis For the immunoblotting analysis, equal amounts of 40 µg liver protein from the HCC and non-HCC samples, and 10 µg from the HepG2 cells were s

• br Training gradient boosting trees classifiers br For each

  2022-04-28

  

  5.4. Training gradient boosting trees classifiers For each Inception-ResNet-v2 model, we build a training dataset of deep feature vectors, extracted from training images in our augmented dataset. Each dataset of deep feature vectors is used to train a gradient boosting classifier to improve fur

• br Mounting data suggests that ctDNA may have

  2022-04-28

  

  Mounting data suggests that ctDNA may have the capacity to track resistance before conventional imaging modalities. Whether this is clinically meaningful is an active area of investigation. In high-heterogeneity cancers, targeted capture sequencing has several advantages over single-gene sequencin

174 records 4/12 page Previous Next 12345 Next 5 pages Last page